Delcath Systems, Inc. filed its quarterly report on Form 10-Q with the SEC for the period ended June 30, 2026, disclosing product revenue, operating income, and balance sheet data for the first half of the fiscal year.

Key Highlights

  • Q2 2026 product revenue: $29,133 thousand, compared with $24,156 thousand in Q2 2025, according to the filing.
  • Six-month product revenue: $54,127 thousand for the first half of 2026, up from $43,940 thousand in the same period of 2025.
  • Net income: $2,668 thousand for the three months ended June 30, 2026, and $1,598 thousand for the six months ended June 30, 2026.
  • Total assets: $137,018 thousand as of June 30, 2026, versus $123,632 thousand at December 31, 2025.
  • Accumulated deficit: $(527,250) thousand at June 30, 2026, compared with $(528,848) thousand at December 31, 2025.
  • Total stockholders' equity: $121,145 thousand at June 30, 2026, up from $111,219 thousand at December 31, 2025.
  • Share repurchases: The company repurchased and retired 317,093 shares of common stock during the first half of 2026, per the equity statements.

Delcath Systems Q2 2026 Operating and Balance Sheet Performance

According to the filing, Delcath Systems, Inc. (Nasdaq Capital Market: DCTH) generated product revenue of $29,133 thousand in the second quarter of 2026, compared with $24,156 thousand in the second quarter of 2025. Gross profit for the three months ended June 30, 2026 was $26,148 thousand, versus $20,838 thousand in the prior-year quarter. The company reported operating income of $2,395 thousand for Q2 2026 and $758 thousand for the six-month period ended June 30, 2026.

The filing discloses that research and development expenses rose to $10,380 thousand in Q2 2026 from $6,882 thousand in Q2 2025, and to $20,204 thousand for the six months ended June 30, 2026, compared with $11,889 thousand in the comparable prior-year period. Selling, general and administrative expenses were $13,373 thousand in Q2 2026 versus $11,366 thousand a year earlier. Interest income of $781 thousand was recorded in Q2 2026, and income tax expense was $491 thousand for the same quarter.

On the balance sheet at June 30, 2026, the company reported cash and cash equivalents of $47,521 thousand, short-term investments of $48,381 thousand, and accounts receivable of $15,942 thousand, according to the filing. Total liabilities stood at $15,873 thousand. Common stock authorized was 80,000,000 shares, with 34,636,252 shares issued and outstanding at June 30, 2026. Share-based compensation expense of $4,876 thousand and $5,054 thousand was recorded in Q1 and Q2 2026, respectively, per the equity statement.

What Was Disclosed

The 10-Q filing covers Delcath Systems' unaudited condensed consolidated financial statements for the quarter and six months ended June 30, 2026, including income, balance sheet, equity, and cash flow data, along with management's discussion and risk factor disclosures.